pVAXrcPSAv53l vaccine
Term · Oncology and biomedicine · MLC-T-ONC-016303
A cancer vaccine containing xenogenic DNA from rhesus macaque (Macaca mulatta) that encodes prostate specific antigen (PSA) with potential immunostimulating and antineoplastic activities. Upon repeated intradermal administration via electroporation, pVAXrcPSAv53l vaccine may induce a cytotoxic T-lymphocyte (CTL) response against PSA-expressing prostate cancer cells. Rhesus PSA is 89% homologous to human PSA.
| Identifier | MLC-T-ONC-016303 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | pVAXrcPSAv53l (DNA encoding rhesus PSA) |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016303",
"term": "pVAXrcPSAv53l vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine containing xenogenic DNA from rhesus macaque (Macaca mulatta) that encodes prostate specific antigen (PSA) with potential immunostimulating and antineoplastic activities. Upon repeated intradermal administration via electroporation, pVAXrcPSAv53l vaccine may induce a cytotoxic T-lymphocyte (CTL) response against PSA-expressing prostate cancer cells. Rhesus PSA is 89% homologous to human PSA.",
"synonyms": [
"pVAXrcPSAv53l (DNA encoding rhesus PSA)"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pvaxrcpsav53l-vaccine/"
}
Record 13,895 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.